Skip to main content
BCWORLDPHARM Co., Ltd. logo

BCWORLDPHARM Co., Ltd. — Investor Relations & Filings

Ticker · 200780 ISIN · KR7200780005 KO Manufacturing
Open in API
Filings indexed 192 across all filing types
Latest filing 2026-02-04 Major Shareholding Noti…
Country KR South Korea
Listing KO 200780

About BCWORLDPHARM Co., Ltd.

https://www.bcwp.co.kr

BCWORLDPHARM Co., Ltd. is a technology-driven pharmaceutical company specializing in the research, development, and manufacturing of prescription drugs. The company leverages its core expertise in formulation and process development to produce a diverse portfolio of quality generic medicines. With a significant commitment to research and development, BCWORLDPHARM focuses on creating next-generation pharmaceuticals to address evolving medical needs and improve patient health outcomes.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership and collateral agreements by major shareholders and special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2026-02-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (BC World Pharm) disclosing a significant change in financial results (revenue or profit/loss structure exceeding 15% for large corporations or 30% for others). This is a standard regulatory disclosure requirement in the Korean market (DART system) for preliminary financial results before the final audit report is finalized. Since it provides key financial highlights and performance metrics rather than being a full annual report or a simple announcement of a report's availability, it falls under the Earnings Release (ER) category.
2026-02-02 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the scheduling of an Investor Relations (IR) presentation/meeting. It provides details such as the date, time, location (online), and purpose of the event. Since it is an announcement of an upcoming event rather than the presentation materials themselves, and it does not fit into specific categories like earnings releases or financial reports, it is classified as a Regulatory Filing (RNS) as it serves as a formal notice to the market.
2025-12-16 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Regulatory Filings
2025-11-07 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Regulatory Filings
2025-11-07 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for BCWORLD PHARM. Co., Ltd., covering the period from January 1, 2025, to June 30, 2025. It contains detailed corporate information, financial data, management discussions, and governance details as required by the Financial Supervisory Service (FSS) and the Korea Exchange. Since it is a comprehensive financial report for a period shorter than a full fiscal year (interim/quarterly), it falls under the 'Interim / Quarterly Report' category. H1 2025
2025-08-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.